Skip to main content

Table 2 Relationship between awareness and AD biomarkers

From: Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease

 

Participants-informants

Objective-subjective

SUVr tau entorhinal

SUVr tau inferior temporal

SUVr tau entorhinal

SUVr tau inferior temporal

Vars

Estimate

SD

ESs

P

Estimate

SD

ESs

P

Estimate

SD

ESs

P

Estimate

SD

ESs

P

(Intercept)

0.38

0.47

  

0.52

0.47

  

0.71

0.97

  

0.75

0.99

  

Age

0

0.01

0

1.000

0

0.01

0

1.000

−0.02

0.01

0.011

0.090

−0.02

0.01

0.009

0.115

Gender

−0.13

0.08

0.008

0.200

−0.12

0.08

0.007

0.245

−0.27

0.16

0.009

0.192

−0.27

0.16

0.008

0.208

Education

0

0.01

0

1.000

0

0.01

0

1.000

0.07

0.03

0.015

0.058

0.06

0.03

0.012

0.101

Clinical status

  

0

0.787

  

0.003

0.249

  

0.006

0.574

  

0.002

1.000

Clinical StatusImpaired

−0.04

0.09

  

−0.09

0.09

  

0.26

0.19

  

0.15

0.19

  

Amyloid

0.12

0.05

0

0.927

0.11

0.05

0

0.659

0.36

0.11

0

0.583

0.37

0.12

0

0.577

Tau

−0.07

0.07

0

0.037*

−0.02

0.1

0

0.023*

−0.17

0.14

0

0.081

−0.23

0.21

0

0.243

Clinical Status:Amyloid

  

0.004

0.201

  

0.005

0.408

  

0.014

0.019*

  

0.032

0.003*

Clinical StatusImpaired:Amyloid

−0.1

0.09

  

−0.1

0.08

  

−0.4

0.18

  

−0.58

0.18

  

Clinical Status:Tau

  

0

1.000

  

0.002

1.000

  

0.001

1.000

  

0.004

0.704

Clinical StatusImpaired:Tau

0.02

0.09

  

0.09

0.13

  

0.12

0.19

  

0.31

0.27

  

Amyloid:Tau

0.11

0.07

0

0.086

0.11

0.09

0

0.004*

0.17

0.15

0

0.087

0.07

0.2

0

0.347

Clinical Status:Amyloid:Tau

  

0.023

0.013*

  

0.015

0.057

  

0.016

0.046*

  

0.002

0.839

Clinical StatusImpaired:Amyloid:Tau

−0.22

0.08

  

−0.22

0.1

  

−0.38

0.17

  

−0.17

0.21

  
  1. Note: SD standard deviation, ESs effect sizes (Cohen’s f2), Amyloid florbetapir PET SUVr, Tau flortaucipir PET SUVr